Patients younger than forty years old with hepatitis C virus genotype-1 chronic infection had treatment responses similar to genotype-2 infection and not related to interleukin-28B polymorphism
Título del documento: Patients younger than forty years old with hepatitis C virus genotype-1 chronic infection had treatment responses similar to genotype-2 infection and not related to interleukin-28B polymorphism
Revista: Annals of hepatology
Base de datos: PERIÓDICA
Número de sistema: 000418090
ISSN: 1665-2681
Autores: 1
1
1
1
1
2
Instituciones: 1Chang Gung Memorial Hospital, Linkou Medical Center, Taouyan. Taiwán
2Chang Gung University, College of Medicine, Taouyan. Taiwán
Año:
Periodo: Feb
Volumen: 12
Paginación: 62-69
País: México
Idioma: Inglés
Tipo de documento: Artículo
Enfoque: Aplicado, analítico
Resumen en inglés Age is one of the predictors for sustained virological response (SVR) when treating chronic hepatitis C (CHC) patients with pegylated-interferon/ribavirin (PegIFN/RBV). However, the treatment responses of the young patients had not been analyzed before. Therefore, we conducted this study to investigate the treatment responses of CHC patients younger than 40 years old (y/o). Material and methods. We retrospectively analyzed our prospective cohort of genotype 1 (GT1)- and genotype 2 (GT2)-CHC patients who received 24-week PegIFN/RBV treatment. We divided these patients into two groups according to their age younger or older than 40 y/o. Clinical parameters including viral responses and single nucleotide polymorphisms (SNPs) of interleukin-28B (IL28B) had been analyzed. Results. In GT1- CHC patients, the rapid, complete early viral response rates and the SVR rate were significantly higher in patients younger than 40 y/o. In GT-1 CHC patients younger than 40 y/o, the SVR rate was similar to the GT2-CHC patients, either with high or low baseline viral load. As for the SVR predictors, in CHC patients younger than 40 y/o, only BMI but not the genotype of HCV, not baseline viral load, and not IL28B SNP was the predictor. Conclusions. GT1-CHC patients younger than 40 y/o had SVR rate similar to GT2-CHC patients. The IL28B polymorphism had no impact on the SVR rate in these young GT1-CHC patients
Disciplinas: Medicina
Palabras clave: Gastroenterología,
Terapéutica y rehabilitación,
Hepatitis C,
Hepatitis crónica,
Interferón alfa,
Polimorfismo de nucleótido único,
Interleucina 28B,
Edad
Keyword: Gastroenterology,
Therapeutics and rehabilitation,
Hepatitis C,
Chronic hepatitis,
Interferon alpha,
Single nucleotide polymorphism (SNPs),
Interleukin 28B,
Age
Texto completo: Texto completo (Ver PDF)